The Blazar™ platform provides researchers with accurate and highly sensitive viral detection in just days. Combining the breadth of detection of NGS with the speed and sensitivity of PCR, Blazar™ relies on degenerate PCR primers for coverage of more than 5000 viral variants. By amplifying multiple targets within a conserved region of the viral family genome, Blazar detects a much broader range of adventitious viruses as compared to traditional PCR methods.
The Blazar™ platform also reduces dependence on in vivo models for virus detection. By replacing the mouse, hamster, and rat antibody production (MAP, HAP and RAP) tests typically used to characterize rodent cells for biologics manufacturing, Blazar™ assays champion the 3Rs (Replacement, Reduction, and Refinement) and meets regulatory imperatives to decrease animal use.
The Blazar™ platform will enable next generation bioprocessing strategies – from process intensification, to connected processing, to fully continuous manufacturing – expediting biomanufacturing timelines thorough enhanced productivity. Used in combination with our BioContinuum™ Platform, the Blazar™ platform offers significant potential to revolutionize biologics production.Maintain a competitive advantage by accelerating your biologics program with the Blazar™ platform for rapid molecular detection.